Breaking News Headlines Today

News from Express Pharma

Your destination for news from Express Pharma. See how Express Pharma’s media bias impacts the breaking news stories of today.

We’ve aggregated 257 of Express Pharma’s headlines and news stories over the past 3 months.

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

Emmanuel Macron · United States

Trump Hones in on Energy in Trade Talks, but Specifics Are Scarce

50% Right coverage: 8 sources

President Trump is seeking to promote U.S. energy in his trade negotiations, but announcements about agreements so far have been light on details, and actual outcomes are largely mysterious. Recently, the Trump administration and the European Union announced a trade deal under which the EU will buy “$750 billion in U.S. energy” by 2028. An EU webpage said that the deal…See the Story

Eli Lilly

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health - Eli Lilly (NYSE:LLY)

75% Center coverage: 8 sources

Eli Lilly's Mounjaro matched Trulicity in heart outcomes and showed added benefits on A1C, weight, kidney function, and mortality in a major trial.See the Story

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across the U.S. and Europe

67% Center coverage: 3 sources

TAMPA, Fla.--(BUSINESS WIRE)--Aug 4, 2025-See the Story

U.S. Trade Policy Is Jeopardising the U.S. - India Pharma Supply Chain - Express Pharma

Earlier this month, President Donald Trump announced plans to raise tariffs on Indian imports to 50 per cent, doubling the already controversial 25 per cent levy imposed just days prior. The move—triggered by India’s continued purchase of Russian oil and its resale on global markets—comes amid rising geopolitical friction and a breakdown in trade negotiations. At first glance, these may seem like geopolitical tit-for-tats. But in reality, they r…Donald Trump · United States See the Story

Intas Pharmaceuticals and Accord BioPharma Expand Global Pegfilgrastim Footprint with UDENYCA Acquisition - Express Pharma

Open the article to view the coverage from Express Pharma See the Story

Zydus Lifesciences receives Health Canada approval for smoking cessation drug - Express Pharma

Zydus Lifesciences, including its subsidiaries and affiliates (collectively referred to as “Zydus”), has received a Notice of Compliance (NOC) from Health Canada for its ZDS-Varenicline tablets in 0.5 mg and 1 mg strengths. This marks the company’s first NOC approval in Canada. Varenicline is indicated as an aid in smoking cessation. It functions as a partial nicotinic acetylcholine receptor agonist, which means it is designed to partially activ…Health Canada · Canada Read Article

QRL Bioscience raises ₹3 crore from GVFL to advance regenerative therapies - Express Pharma

QRL Bioscience has raised ₹3 crore in its latest funding round from GVFL, a venture capital firm based in India. The capital will support clinical and preclinical work on the company’s regenerative therapies for diabetic foot ulcers (DFU) and osteoarthritis. Founded by Dr Senthilkumar Natesan, Mr. Sanjoy Bhagat, and Dr Kranti Vora, QRL Bioscience is focused on personalised, cell-based therapies for chronic degenerative diseases. Dr Natesan is a …India · India Read Article

Industry experts weigh in on US tariff exemption for Indian pharma amid section 232 review - Express Pharma

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance (IPA): “The recent Executive Order by the US Administration excludes the pharmaceutical sector from immediate tariff imposition. The sector is being reviewed under Section 232 investigation. Generic medicines are important for affordable healthcare in the US and typically operate on razor-thin margins. Ensuring their consistent availability is critical for patient care. India–US p…India · India Read Article

ENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push - Express Pharma

ENTOD Pharmaceuticals has introduced new research-led treatments in ophthalmology and dermatology, driven by its Mumbai-based R&D centre. These developments include what the company calls the world’s first eye drop to slow myopia progression in children aged 6 to 12 and a collagen-based transdermal serum designed for layered skin regeneration. The company’s prescription-only eye drop is aimed at addressing childhood myopia, which ENTOD Pharmaceu…Mumbai · Mumbai Read Article

Apollo AyurVAID, NTBGRI Partner to Advance R&D in Ayurveda-Based Herbal Drug Development & Standardisation - Express Pharma

Apollo AyurVAID signed a Memorandum of Understanding (MoU) with the Jawaharlal Nehru Tropical Botanic Garden and Research Institute (JNTBGRI), an autonomous R&D institution under the Kerala State Council for Science, Technology and Environment (KSCSTE), to foster collaborative research in herbal drug development and standardisation. The MoU was formally exchanged during the KSCSTE R&D Summit 2025, held in the presence of Pinarayi Vijayan, Chief …Thiruvananthapuram · Thiruvananthapuram See the Story

SCHOTT expands glass tubing production capabilities in India to include syringes and cartridges - Express Pharma

SCHOTT, a global company in specialty glass, has announced the addition of syringe and cartridge glass tubing production at its manufacturing facility in Jambusar, Gujarat. The company stated that this expansion makes it Asia’s largest producer of syringe and cartridge glass tubing and strengthens its support for the Indian government’s ‘Make in India’ initiative. According to SCHOTT, the new capabilities in Jambusar are based on a direct techno…Gujarat · Gujarat Read Article

News from Express Pharma

News from Express Pharma

Information about Express Pharma

Media Bias Ratings

Factuality

Ownership

Top Express Pharma News

Trump Hones in on Energy in Trade Talks, but Specifics Are Scarce

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health - Eli Lilly (NYSE:LLY)

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding Its Coronary Clinical Program Across the U.S. and Europe

U.S. Trade Policy Is Jeopardising the U.S. - India Pharma Supply Chain - Express Pharma

Intas Pharmaceuticals and Accord BioPharma Expand Global Pegfilgrastim Footprint with UDENYCA Acquisition - Express Pharma

Zydus Lifesciences receives Health Canada approval for smoking cessation drug - Express Pharma

QRL Bioscience raises ₹3 crore from GVFL to advance regenerative therapies - Express Pharma

Industry experts weigh in on US tariff exemption for Indian pharma amid section 232 review - Express Pharma

ENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push - Express Pharma

Apollo AyurVAID, NTBGRI Partner to Advance R&D in Ayurveda-Based Herbal Drug Development & Standardisation - Express Pharma

SCHOTT expands glass tubing production capabilities in India to include syringes and cartridges - Express Pharma

Similar News Topics

Topics Most Covered by Express Pharma

Sources Covering Similar Topics

Breaking News Topics Related to Express Pharma

Information about Express Pharma

Media Bias Ratings

Factuality

Ownership

U.S. Trade Policy Is Jeopardising the U.S. - India Pharma Supply Chain - Express Pharma

Intas Pharmaceuticals and Accord BioPharma Expand Global Pegfilgrastim Footprint with UDENYCA Acquisition - Express Pharma

Zydus Lifesciences receives Health Canada approval for smoking cessation drug - Express Pharma

QRL Bioscience raises ₹3 crore from GVFL to advance regenerative therapies - Express Pharma

Industry experts weigh in on US tariff exemption for Indian pharma amid section 232 review - Express Pharma

ENTOD Pharmaceuticals launches Myopia therapy and collagen serum in new R&D push - Express Pharma

Apollo AyurVAID, NTBGRI Partner to Advance R&D in Ayurveda-Based Herbal Drug Development & Standardisation - Express Pharma

SCHOTT expands glass tubing production capabilities in India to include syringes and cartridges - Express Pharma